CLIC1 has been reported as a potential biomarker and therapeutic target for some tumors such as oral squamous cell carcinoma, ovarian cancer, and hepatocellular carcinoma [29,30]. The gene discussed is CLIC1; the disease is oral cavity squamous cell carcinoma.